DB14817Investigational
Pegapamodutide is under investigation in clinical trial NCT02188303 (A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants).
- Mechanism
- Curator reviewed
Pharmacologically active on Glucagon-like peptide 1 receptor
- Code names
- LY2944876
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Pegapamodutide, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account